eCite Digital Repository
A randomized controlled trial examining combinations of repaglinide, metformin and NPH insulin
Citation
Davies, MJ and Thaware, PK and Tringham, JR and Howe, J and Jarvis, J and Johnston, V and Kitchener, DL and Skinner, TC and McNally, PG and Lawrence, IG, A randomized controlled trial examining combinations of repaglinide, metformin and NPH insulin, Diabetic Medicine, 24, (7) pp. 714-719. ISSN 0742-3071 (2007) [Refereed Article]
 | PDF Not available 100Kb |
Copyright Statement
The definitive published version is available online at: http://www3.interscience.wiley.com/
Official URL: http://dx.doi.org/10.1111/j.1464-5491.2007.02128.x
DOI: doi:10.1111/j.1464-5491.2007.02128.x
Abstract
Aims: To compare combination use of repaglinide, metformin and bedtime Neutral Protamine Hagedorn (NPH) insulin with conventional approaches of insulin initiation in patients with Type 2 diabetes (T2DM). Methods: Eighty-two patients with T2DM with suboptimal glycaemic control on oral glucose-lowering agents were randomized to one of three treatment regimens for 4 months. Group 1 received metformin and twice daily biphasic 30/70 human insulin mixture (n = 27), group 2 metformin and bedtime NPH insulin (n = 26) and group 3 metformin, bedtime NPH insulin and mealtime repaglinide (n = 25). Results: Seventy-five patients completed the study. Baseline and end-point mean HbA1c levels fell from 9.0 ± 1.1 to 7.9 ± 1.1% in group 1, 10.0 ± 2.2 to 9.2 ± 1.4% group 2 and 10.0 ± 1.7 to 8.1 ± 1.5% in group 3, respectively. All groups showed improvements in HbA1c. There was no significant difference between groups in the proportions of patients experiencing hypoglycaemia (29.6, 25.0 and 16.7%, respectively; P = 0.55) or in mean weight gain (2.9, 0.7 and 2.2 kg, respectively; P = 0.06). By 4 months, insulin doses were 0.63 ± 0.32 IU/kg in group 1, 0.58 ± 0.21 IU/kg in group 2 and 0.37 ± 0.22 IU/kg in group 3 (group 3 vs. groups 1 and 2: P < 0.002). Conclusions: The approach using repaglinide, metformin and NPH insulin improved glycaemic control with a similar safety profile to conventional insulin initiation in T2DM and produced final glycaemic control similar to metformin and a twice daily biphasic insulin mixture. © 2007 The Authors.
Item Details
| Item Type: | Refereed Article |
|---|---|
| Research Division: | Biomedical and Clinical Sciences |
| Research Group: | Clinical sciences |
| Research Field: | Endocrinology |
| Objective Division: | Health |
| Objective Group: | Clinical health |
| Objective Field: | Clinical health not elsewhere classified |
| UTAS Author: | Skinner, TC (Professor Timothy Skinner) |
| ID Code: | 74174 |
| Year Published: | 2007 |
| Web of Science® Times Cited: | 11 |
| Deposited By: | Research Division |
| Deposited On: | 2011-11-15 |
| Last Modified: | 2012-02-16 |
| Downloads: | 1 View Download Statistics |
Repository Staff Only: item control page